Edition:
India

XBiotech Inc (XBIT.OQ)

XBIT.OQ on NASDAQ Stock Exchange Global Select Market

4.17USD
15 Dec 2017
Change (% chg)

$-0.30 (-6.71%)
Prev Close
$4.47
Open
$4.48
Day's High
$4.49
Day's Low
$4.05
Volume
629,429
Avg. Vol
38,491
52-wk High
$20.18
52-wk Low
$2.80

Select another date:

Wed, Oct 18 2017

BRIEF-XBIOTECH ‍ENROLLS FIRST PATIENT IN STUDY EVALUATING MABP1 IN WITH ONIVYDE

* ‍ENROLS FIRST PATIENT IN STUDY EVALUATING MABP1 IN COMBINATION WITH ONIVYDE & 5-FLUOROURACIL/FOLINIC ACID FOR TREATMENT OF PANCREATIC CANCER​ Source text for Eikon: Further company coverage:

BRIEF-XBiotech announces agreement with Cedars-Sinai Medical Center to evaluate MABP1 combination for the treatment of pancreatic cancer

* Xbiotech announces agreement with Cedars-Sinai Medical Center to evaluate MABP1 in combination with Onivyde and 5-fluorouracil/folinic acid for the treatment of pancreatic cancer Source text for Eikon: Further company coverage:

BRIEF-XBiotech - European Medicines Agency maintains its May 18, 2017 opinion

* XBiotech - on Sept 14, although there were advancements in certain areas of application European Medicines Agency has maintained its May 18, 2017 opinion

Select another date: